Pamela H. Patsley
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
TXN Announces Q3 Earnings Preview and Q4 2026 Dividend. Texas Instruments will report Q3 earnings next week, with analysts noting key metrics that could influence expectations. The board also declared a quarterly dividend for Q4 2026, adding to shareholder value. These developments keep the stock in focus for investors monitoring earnings performance and dividend policy.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Keurig Dr Pepper Faces Acquisition Uncertainty and Commodity Risk Re‑emergence. Keurig Dr Pepper is navigating uncertainty around a potential acquisition or spin‑off, while commodity price swings are returning to the mix. The 2.64% dividend yield has prompted questions about the company’s payout strategy, and a recent CEO change along with a 2027 beverage push could shift the bullish narrative. Some analysts note that consumer staples stocks, including Keurig Dr Pepper, have lagged this year. The stock is near the top of its 52‑week range and sits close to the $30.73 support level, with an RSI of 69.4 indicating a high‑end reading.
Transaction History
| HGV | ▲ Buy | Grant | 4,114 | $0 | 5/6/2026 | View on chart |
| TXN | ▲ Buy | Option Exercise | 4,306 | $474K | 4/24/2026 | View on chart |
| TXN | ▼ Sell | Open Market | 4,306 | $1.2M | 4/24/2026 | View on chart |
| KDP | ▲ Buy | Option Exercise | 5,226 | $0 | 3/3/2026 | View on chart |
| TXN | ▲ Buy | Grant | 525 | $0 | 1/29/2026 | View on chart |
| HGV | ▲ Buy | Grant | 5,256 | $0 | 5/7/2025 | View on chart |
| KDP | ▲ Buy | Option Exercise | 6,960 | $0 | 3/12/2025 | View on chart |
| TXN | ▲ Buy | Grant | 614 | $0 | 1/27/2025 | View on chart |
| TXN | ▲ Buy | Option Exercise | 6,065 | $481K | 8/29/2024 | View on chart |
| TXN | ▼ Sell | Open Market | 1,913 | $405K | 8/29/2024 | View on chart |
| TXN | ▼ Sell | Open Market | 4,152 | $883K | 8/29/2024 | View on chart |
| HGV | ▲ Buy | Grant | 4,608 | $0 | 5/8/2024 | View on chart |
| TXN | ▲ Buy | Option Exercise | 9,990 | $529K | 4/29/2024 | View on chart |
| TXN | ▼ Sell | Open Market | 9,990 | $1.8M | 4/29/2024 | View on chart |
| KDP | ▲ Buy | Option Exercise | 6,143 | $0 | 3/4/2024 | View on chart |
| TXN | ▲ Buy | Grant | 686 | $0 | 1/25/2024 | View on chart |
| KDP | ▲ Buy | Option Exercise | 6,631 | $0 | 9/13/2023 | View on chart |
| TXN | ▲ Buy | Option Exercise | 10,539 | $568K | 7/27/2023 | View on chart |
| TXN | ▼ Sell | Open Market | 10,539 | $1.9M | 7/27/2023 | View on chart |
| HGV | ▲ Buy | Grant | 4,342 | $0 | 5/3/2023 | View on chart |
| TXN | ▲ Buy | Grant | 574 | $0 | 1/26/2023 | View on chart |
| TXN | ▲ Buy | Option Exercise | 12,299 | $542K | 7/29/2022 | View on chart |
| TXN | ▼ Sell | Open Market | 12,299 | $2.2M | 7/29/2022 | View on chart |
| HGV | ▲ Buy | Grant | 3,878 | $0 | 5/4/2022 | View on chart |
| TXN | ▲ Buy | Grant | 572 | $0 | 1/27/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
HGV: JP Morgan Adds Neutral Coverage, Sets $39 Target
JP Morgan has started coverage of Hilton Grand Vacations, giving it a neutral rating and a $39 price target. The firm notes that macro concerns may be overstated, suggesting a buying opportunity. Meanwhile, HGV is promoting its 2027 Tournament of Champions, adding a musical lineup to its event calendar. These developments add fresh context to the stock’s valuation and future outlook.
HGV: JP Morgan Adds Neutral Coverage, Sets $39 Target. JP Morgan has started coverage of Hilton Grand Vacations, giving it a neutral rating and a $39 price target. The firm notes that macro concerns may be overstated, suggesting a buying opportunity. Meanwhile, HGV is promoting its 2027 Tournament of Champions, adding a musical lineup to its event calendar. These developments add fresh context to the stock’s valuation and future outlook.